The Front Room — a clinical regulatory commons
RSS
GUIDANCE Draft Draft

Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations

FDA · 2024 U.S. Food & Drug Administration
ABSTRACT — EDITORS' SUMMARY

Guidance on the diversity action plan required by FDORA §3602. Structure, content, submission timing. Intersects with E6(R3) §3.1 trial design.

EMBEDDED PDF
PDF CURRENTLY UNAVAILABLEFDA pulled the source PDF for this document. The landing page may still be live with the document's metadata and history, but the file itself isn't downloadable right now. (PDF pulled from FDA CDN (media/179593 returns 404 as of May 2026). Landing page remains live. Likely affected by Trump administration website restoration order. Monitor for restoration via weekly health check.)
VIEW LANDING PAGE
METADATA
TypeGUIDANCE
Year2024
VersionDraft
StatusDraft
FormatPDF
Pages31
Size880 KB
Last reviewedJUN 2024
SOURCE
PDF · CANONICAL LINK https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-action-plans-improve-enrollment-participants-underrepresented-populations
RELATED · SAME AUTHORITY